Tom Walls
Tom Walls is principal and founder of Axon Bridge Consulting, specializing in advanced therapy medicinal products (ATMP) supply chain planning. With over 20 years of life sciences supply chain experience, he previously served as head of supply chain planning at Spark Therapeutics and has published in Cell & Gene Therapy Insights. He is the author of A Practical Guide to ATMP Supply Chain Planning and Orchestration Excellence and developed the R3M (Risk Measurement, Monitoring, and Mitigation) framework for ATMP supply chains. Contact: tom@axonbridgeconsulting.net.
ARTICLES BY TOM WALLS
-
![Medical team, tablet, meeting-GettyImages-2177971058]( "How Clinical Supply Teams Pull Better Demand Signals")
2/6/2026Clinical supply teams reduce risk by using site-level enrollment data, screen failure rates, and amendment impacts to guide material commitments and plan for uncertainty.
-
![supply vs demand-GettyImages-1333357430]( "Why Clinical Supply Risk Starts With Demand Signals")
2/5/2026Clinical supply risk often begins long before manufacturing or distribution. Flawed demand signals and enrollment forecasts can quietly create shortages, delays, and costly material waste.
-
![Managers inspecting inventory in warehouse, medical supplies-GettyImages-2210267081]( "Sales & Operations Planning for Small Teams: Aligning Clinical Supply")
1/6/2026Small clinical teams don’t fail at S&OP from missing systems—they fail from unclear demand and decisions. Alignment comes from discipline, shared visibility, and acting on reality before timelines slip.
